Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. - Wikidata - wikimedia - TriplyDB

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

http://www.wikidata.org/entity/Q34186632

about

Renal cell carcinoma: Evolving and emerging subtypes State of the science: an update on renal cell carcinoma Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms Renal tumors: diagnostic and prognostic biomarkers Clear cell papillary renal cell carcinoma: a review.Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas.Sporadic hemangioblastoma of the kidney with PAX2 and focal CD10 expression: report of a case.Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity.Case report: Papillary mesothelioma of the peritoneum with foamy cell lining.Case report: Intraductal tubulopapillary neoplasm of the pancreas with unique clear cell phenotype.Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features.Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome.Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity.Expression of Von Hippel - Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma.A clear cell renal cell carcinoma inhibiting the response to intravitreal antivascular endothelial growth factor therapy in wet age-related macular disease.Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations.Cytopathologic features of clear cell papillary renal cell carcinoma: A recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms.Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential?Cytomorphology of clear cell papillary renal cell carcinoma.Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.Biosynthesis, characterization, and evaluation of bioactivities of leaf extract-mediated biocompatible gold nanoparticles from Alternanthera bettzickiana.Systemic therapy in metastatic renal cell carcinoma

P2860

Q24629153-FBF9178D-A0B7-4408-BE28-3B59C08E07BF Q24630685-9514A7C2-2207-483C-9916-0BCA5138DF25 Q26752945-C7B06296-87FF-4582-BDDF-0988DBCFFAAC Q26785930-748DF35D-5432-4966-BD17-5F1A997A08C3 Q26860500-699A0D47-D7ED-45EC-B836-043BDA2697CF Q34732925-E4FE1338-6EE2-4618-969A-24F3E15A066E Q34758616-710D48E6-4A88-4DD4-BA72-2ACB6C4FB3AA Q35096116-B1E95707-962D-4E36-A27F-08BAD2893916 Q35667690-E75BDD6C-6487-452B-8CFB-0A0B21BAA3B7 Q35738410-0B07B629-2DAA-4D01-813A-0A9E834A9C95 Q35947018-CDB8933C-DE2D-4541-9BD6-DD07F543C931 Q36518757-19A8FF62-393C-490C-AA12-7F0344F09A57 Q37138045-D1C86B9D-14EC-42D5-8A78-B75B15ABFA31 Q37349521-8F4FA17C-1535-4A28-AA9E-EF6D00DE14FE Q37369747-0DEF1C0E-8A1D-418B-80CE-5CC0B40AB9CD Q37607568-7FF7C4D2-BDAA-48A7-9E4A-8CB7B8AF2561 Q38067125-A22F0BE3-7E31-468D-A8AF-11A13A4E1645 Q38124228-29185F71-C11D-4482-B88B-9B8850424938 Q38383806-794F9616-4946-4C02-8EB4-B6A5C5204C35 Q39124690-510FE9E7-3E93-43BA-8FA2-FDD404B30965 Q39427619-D74F50D5-78AE-40D1-B957-48BC418A607A Q42465071-1DD04E3C-62D8-4607-B168-DF905EB2A5CA Q42768997-58FACA5E-3906-4A6F-8A96-FE4DCF80E6AF Q42913067-29A2F505-4751-4733-A95C-718E5B0208AF Q43408532-65504A4B-10F9-47AE-A47E-26BB4B12927F Q43744999-D4FE9DF1-63B9-4DC5-A983-55D2155FE969 Q44178608-9FE58373-F5FF-4590-90C9-D3D81207CB32 Q45031258-025E53DB-2F1B-4177-A2ED-087DD80A3FD8 Q46831463-4B1DF66A-B2E1-4108-80DF-90E6AD6DC297 Q48963070-206DCC55-1D0E-4BB3-A002-5432E6A9A560 Q51498926-9EBA3D19-6E0D-4D23-8278-D7B7D1D87E03 Q52981878-BF6E9AB2-2CA8-44FE-A0E5-0D8EBA7B35A8 Q55513638-071E3DC1-F55D-40B1-BD78-B2D3F76C1583 Q56966129-D1C7B9E1-D209-4E4F-AB7D-F6065DAC9FA6

P2860

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.

http://www.wikidata.org/entity/Q34186632

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@ast

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@en

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@nl

type

label

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@ast

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@en

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@nl

prefLabel

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@ast

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@en

Clear-cell papillary renal cel ...... ctor pathway-related proteins.

@nl

P1433

Q34186632-8644005C-3300-4D2B-890D-1BB160782D83

P1476

Q34186632-A6C51F8E-E6C1-415B-98EE-C607DC494424

P2093

Q34186632-01EBF423-8F75-40D1-BFB4-751171D36022

Q34186632-3B2BA8FC-A4EC-4F0B-AADC-538181133905

Q34186632-489A0818-A3A3-49C6-B9CE-A462B93AECA2

Q34186632-55A7D8E2-929A-47EC-A3F4-1CEC9C29E27F

Q34186632-6D9A0FE7-BDF7-4010-B8D5-94C94ADD4F55

Q34186632-8D6D3C71-6377-4C46-A8DC-C7D39CB0089B

Q34186632-A9837EAA-D56A-4981-85A3-4582F5AF7F11

Q34186632-B0E9E7EE-6BAD-4725-9A63-F371EE833BEF

Q34186632-DF73CAF8-8E62-40A9-8D3B-9E5BD294903C

Q34186632-E4F18BE3-DD62-485A-8EFA-22F409A0B065

P2860

Q34186632-045B1ACE-BE8E-485A-847B-980904A7209C

Q34186632-1E9A857A-92C6-4D19-8E41-F4600C310E1C

Q34186632-21643FC6-9C38-45D4-A5FD-5417077D91F0

Q34186632-3D18B35F-5B83-48CA-9DB3-4A860299C48D

Q34186632-3F210035-AD84-4934-970B-3677705EB97A

Q34186632-45D4A184-ED6F-42E9-8F85-E147A10C3426

Q34186632-4DCBEDCF-2F08-4148-AFED-B32A24CC240F

Q34186632-519AF7B8-4756-4A42-A585-76EB589C4414

Q34186632-522B9FBD-639D-4BDC-943E-2BB0C1E351FE

Q34186632-6638E16D-93E1-4F60-8AE3-E2BD170BF091

P2888

Q34186632-3EF4FD5B-B12D-4CA0-B229-5FF565064C29

P304

Q34186632-0ED9CE58-4231-4205-8977-D343D60B5742

P31

Q34186632-82ED7308-6BA9-40EA-879E-365B706447B1

P356

Q34186632-03B19229-7D6E-4C5A-80D7-B5926DF55FC8

P433

Q34186632-878095CB-05D3-4F09-BBF9-0FA0A4DD8F8F

P478

Q34186632-34996D93-5076-4FBE-8D67-01EE7400B129

P50

Q34186632-0DCC3B35-9C8E-433F-A576-E114E44AA5F6

P577

Q34186632-80408C91-165A-46B0-8B49-6D5B9D702BF5

P5875

Q34186632-A3E9F9A1-CA28-467A-8C1A-8CB38EC6558F

P6179

Q34186632-271333B6-5E1B-4B25-8BC0-B2D1B4349CF6

P698

Q34186632-7AC8BBFD-306B-471F-A897-058D44B7260B

P921

Q34186632-A5F556FB-B00B-4B2A-841D-39B6EBEF72AC

Q34186632-BE2B9B1B-1595-4123-979A-8BEF5295842C

Q34186632-E2C50D0E-63F1-4B96-A4E4-644FCFC63EF2

P356

MODPATHOL.2011.80

P1433

Modern Pathology

P1476

Clear-cell papillary renal cel ...... actor pathway-related proteins

@en

P2093

Anuradha Gopalan

http://www.w3.org/2001/XMLSchema#string

Marc K Rosenblum

http://www.w3.org/2001/XMLSchema#string

Maria E Dudas

http://www.w3.org/2001/XMLSchema#string

Paul Russo

http://www.w3.org/2001/XMLSchema#string

Samson W Fine

http://www.w3.org/2001/XMLSchema#string

Satish K Tickoo

http://www.w3.org/2001/XMLSchema#string

Stephen M Rohan

http://www.w3.org/2001/XMLSchema#string

Victor E Reuter

http://www.w3.org/2001/XMLSchema#string

Yonghong Xiao

http://www.w3.org/2001/XMLSchema#string

Yupu Liang

http://www.w3.org/2001/XMLSchema#string

P2860

miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

Circular binary segmentation for the analysis of array-based DNA copy number data

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin

Functional copy-number alterations in cancer.

Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number

Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma

Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors.

Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.

P2888

modpathol.2011.80

P304

1207-1220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2011.80

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Hikmat Al-Ahmadie

P577

2011-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51156402

http://www.w3.org/2001/XMLSchema#string

P6179

1043000236

http://www.w3.org/2001/XMLSchema#string

P698

21602815

http://www.w3.org/2001/XMLSchema#string

P921

Clear cell papillary renal cell carcinoma

immunohistochemistry